Stay updated on BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.

Latest updates to the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page
- Check5 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page metadata or formatting. This update does not modify the study details or other substantive content.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a backend/template release. No study data or visible content on the page was altered.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page now displays a newer ClinicalTrials.gov site revision/version identifier (“Revision: v3.5.3”) instead of the previous one (“v3.5.0”). This reflects a system/UI update rather than a change to the study details.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check99 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check120 days agoChange DetectedThe page shows a new revision label, 'v3.4.2', replacing 'v3.4.1'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.